The aminoacylation reaction, which is catalysed by aminoacyl-tRNA synthetases (aaRSs), fuses each amino acid to its cognate tRNA. This reaction requires amino acid activation through condensation of the amino acid with ATP to form an aminoacyl adenylate. The activated amino acid is then transferred to the 3′ end of the cognate tRNA (BOX 1). Because the cognate tRNAs harbour the anticodon triplets of the genetic code, the specific aminoacylations catalysed by the aaRSs establish the rules of the universal genetic code. Thus, aaRSs arose early in evolution, perhaps replacing the activities of ribozymes, the first catalysts of aminoacylations, as the transition was made from the RNA to the protein world.
. These two architectures are thought to have arisen from opposite (that is, complementary) strands of RNA genomes that may have existed in the RNA world and that encoded a class I (strand 1) and a sister class II (complementary strand 2) aaRS 3, 4 . The complementary sister aaRSs can be modelled to bind simultaneously to opposite sides of the tRNA acceptor stems, thereby covering much of the tRNA 5, 6 . They could have served, among other possibilities, as chaperones to protect the tRNA substrate from destruction by nucleases and phosphate bond-cleaving metal ions. Apart from the well-conserved catalytic units, many aaRSs made later additions of less-conserved anticodon-binding domains to more efficiently recognize tRNAs.
In addition to the aminoacylation functions, about half of the aaRSs added an editing function, which enables removal of the wrong amino acid from its cognate tRNA 7 . These aaRSs face a greater challenge to differentiate the cognate verses the noncognate amino acid (for example, Ile from Val) than the others. This editing function is an important mechanism to prevent mistranslation, during which the wrong amino acid is inserted at a specific codon. For life to thrive, the challenge of preventing mistranslation through the mischarging of tRNA had to be overcome. For this reason, the addition of an editing domain to an aminoacylation domain happened before the time that the three kingdoms of life diverged from the last universal common ancestor (LUCA), with strong selective pressure ever since to keep both domains throughout evolution 8 . Throughout evolution, aaRSs have also incorporated domains with no apparent connection to their aminoacylation re actions. In this Opinion, we investigate the general logic and purpose of these new domains, especially in eukaryotes. As described below, our analysis shows that these domain additions were accretive and progressive, following the increasing complexity of eukaryotic organisms. We also find that this ensemble and pattern of domain additions was specific to aaRSs. Importantly, a close inspection of the pattern of domain additions shows that the new functions that have been identified for some of these domains were introduced at precise times in evolution and were associated with the appearance of a new biological function (such as a circulatory system). This observation raises the possibility that the domain additions played an important part in expanding the complexity and sophistication of newly emerging organisms. Abstract | Over the course of evolution, eukaryotic aminoacyl-tRNA synthetases (aaRSs) progressively incorporated domains and motifs that have no essential connection to aminoacylation reactions. Their accretive addition to virtually all aaRSs correlates with the progressive evolution and complexity of eukaryotes. Based on recent experimental findings focused on a few of these additions and analysis of the aaRS proteome, we propose that they are markers for aaRS-associated functions beyond translation.
Box 1 | Basic function of aaRSs
Aminoacyl-tRNA synthetases (aaRSs) provide the first resource for the production of proteins. The algorithm of the genetic code is established in this first reaction of protein synthesis. In this reaction, aaRSs catalyse the attachment of amino acids to their cognate tRNAs that bear the triplet anticodons of the code. These enzymes catalyse the attachment of amino acids in a two-step reaction. The amino acid (aa) is first condensed with ATP to form a tightly bound aminoacyl adenylate (aa-AMP), and inorganic pyrophosphate (PP i ) is released: aa + ATP + aaRS → aaRS(aa-AMP) + PP i
The activated aa-AMP is then transferred from the adenylate to the 3′ end of the tRNA to form aa-tRNA. This also releases AMP and the aaRS: aaRS(aa-AMP) + tRNA → aa-tRNA + AMP + aaRS Because of their essential role in protein synthesis, genes encoding aaRSs appeared when life began 1 . As a family of 20 enzymes in general (one for each amino acid), aaRSs are constrained by evolutionary pressure to preserve this essential activity, but they still managed to develop additional functions during evolution.
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Annotation of new domains and motifs
With a clear understanding of the essential role and logic of the aminoacylation and editing domains, we were surprised to find that, as the tree of life ascended, aaRSs progressively added domains and sequence motifs that are connected to neither aminoacylation nor editing. TABLE 1 displays an annotation of shared domains or motifs (those in more than one synthetase) and unique domains or motifs (those in a specific synthetase) found in the eukaryotic aaRS proteome. The five shared domains or motifs are structural modules that are similar to those seen in other proteins, such as a specialized version of the helix-turnhelix motif known as the WHeP domain, the oligonucleotide binding fold-containing emAPII domain that is also found in p43 (an auxiliary factor found in the multi-aaRS complex (mSC) of eukaryotes), the Leuzipper motif, the glutathione S-transferase (GST) domain and a specialized aminoterminal helix (N-helix) 9 . These domains were added to specific aaRSs as the tree of life ascended from lower to higher eukaryotes. Because the Leu-zipper motif and the WHeP and GST domains are used for forming complexes with other proteins 10 , and because the emAPII domain can function as a cytokine when cleaved from the aaRS or p43 by binding to a cell surface receptor 11 , these domain additions are strongly suggestive of an interaction with a partner protein [12] [13] [14] [15] . Unlike the shared domains, the eight unique sequence motifs are specific to only one synthetase. With the exception of PheRS, the eight unique sequence motifs are not similar to any that we could find from searching sequence databases of all bacterial or archaeal aaRSs. In addition, apart from PheRS and GlnRS, their sequence is not similar to those of non-synthetase proteins. We designate these unique sequences as UNe-L, UNe-S and so on, in which the single letter designates the amino acid type of the synthetase that harbours the specific unique domain (so UNe-L is associated with LeuRS and UNe-S with SerRS). These unique domains and motifs were added to specific aaRSs at distinct points in evolution. Similarly to the shared domains and motifs, UNe domains were grafted onto the canonical aaRS long after the amino acylation function was established. Importantly, with the exception of metRS, these shared and unique domains or motifs were irreversibly retained by the respective aaRS until humans evolved. GST, glutathione S-transferase domain; LZ, Leu-zipper motif; MSc, multi-aaRS complex; NA, not applicable. *each added sequence was checked by iterative searching of the non-redundant database of NcBi using PSiBLAST. Unique, unfamiliar domains (termed UNes) are defined when no homologous sequences (e value < 0.005) were found in other aminoacyl-tRNA synthetases (aaRSs) after the PSiBLAST converged. Also, with the exception of PheRS, the eight UNes are not similar to any in sequence databases of all bacterial or archaeal tRNA synthetases. Furthermore, apart from PheRS and GlnRS, no UNe bears similarity (e value < 0.005) to sequences found in non-synthetase proteins. ‡
The only aaRS to not irreversibly retain domains. § D. melanogaster MetRS has three WHeP domains at the carboxy terminus (interPro: A1ZBe9), which were not found in the previous reports. 
Connecting new domains to new functions
Novel functions that are distinct from their role in translation have been identified for a few human aaRSs. Three examples of these functions, which depend on the addition of one or more new domains or motifs, are given below. many additional examples are anticipated to emerge in the future as more and more of these new structural units are investigated.
TyrRS. FIGURE 1a traces the addition of two new sequence and structural elements to TyrRS in evolution. The tripeptide eLR (Glu-Leu-Arg) and the emAPII domain were added at the stage of insects and have been retained ever since. Neither eLR nor emAPII is found in lower eukaryotic, archaeal or bacterial TyrRSs. Although emAPII is fused to the carboxy terminus of the catalytic domain of TyrRS, eLR is in the catalytic domain itself. However, mutations in eLR or ablation of emAPII had little effect on the aminoacylation activity [16] [17] [18] . These observations suggest that the additions of eLR and emAPII to higher eukaryotic TyrRSs are associated with new functions that are not related to aminoacylation. Furthermore, because the two additions occurred simultaneously, each might be needed for the development of the same new function.
Indeed, both additions are known to work in concert in receptor-mediated signalling pathways that are associated with angiogenesis 19 . eLR is the signature sequence of CXC chemokines that have angiogenic activity by binding CXC-chemokine receptor 1 (CXCR1) or CXCR2 (REF. 20 ).
emAPII binds α5β1 integrin receptor on the surface of endothelial cells and inhibits integrin-dependent cell adhesion and spreading. Furthermore, following internal ization by endothelial cells, emAPII inhibits hypoxia-inducible factor 1α (HIF1α)-regulated angiogenesis 21 . Two high resolution crystal structures of human TyrRS suggested an autoinhibitory structure in which the emAPII domain of TyrRS blocks eLR, making it inaccessible to its receptors on the cell surface and thereby shielding or muting the embedded angiogenic activity of TyrRS 22, 23 . After secretion of TyrRS, removal of emAPII by proteolytic cleavage unmasks the eLR tripeptide motif. Thus, the two additions -a new domain (emAPII) and a new tripeptide motif (eLR) -to TyrRS are connected to the same function.
TrpRS. FIGURE 1b traces the addition of the WHeP domain to TrpRS. The new domain was added at the stage of chordates and has been retained ever since. This domain has been found to have a regulatory function, as it inhibits the activation of the angiostatic activity of TrpRS that evolved in higher eukaryotes. TrpRS is strongly upregulated by interferon-γ (IFNγ), along with other angio static factors such as mIG (also known as CXCL9) and 10 kDa IFNγ-induced protein (IP10; also known as CXCL10) 24 . Indeed, removal of WHeP (by alternative splicing or proteolysis) activates TrpRS as a potent angio static factor [25] [26] [27] , which then binds to vascular endothelial cadherin (Ve-cadherin; a protein involved in endothelial cell adhesion and consequently angiogenesis) 28 . Strikingly, two protruding Trp side chains near the N terminus of Ve-cadherin fit into the aden ylate pocket (made up of Trp and AmP subpockets) of TrpRS, thereby inducing Ve-cadherin-TrpRS complex formation 29 . High-resolution crystal structural analysis of human TrpRS showed that the position of the WHeP domain makes the subpockets sterically inaccessible to Ve-cadherin while still allowing entry of the small molecule substrates (Trp and AmP) so as not to interfere with aminoacylation 30 . Similarly to TyrRS, at least one role for the newly added domain is to regulate the accessibility of a signalling motif in TrpRS that interacts with its cognate receptor.
GluRS-ProRS.
A third example, which also involves a WHeP domain, is the unusual GluRS-ProRS (ePRS) fusion enzyme. In this case, the WHeP domain serves as a linker to join the two aaRSs. The WHeP domain first appeared in GluRS and ProRS in nematodes and was retained (in ePRS) ever since 31 (FIG. 1c) . ePRS is part of the mSC found in higher eukaryotes 32 . earlier work showed that, after stimulation with IFNγ, ePRS is phosphorylated and released from the mSC and then becomes part of the IFNγ-activated inhibitor of translation (GAIT) complex. This complex subsequently silences translation by binding (mediated by WHeP) to a stem loop structure (known as the GAIT element) in the 3′ untranslated region of one or more mRNAs that function in pathways for inflammation and iron homeostasis 33 . Thus, ePRS is linked to the inflammatory 
response. ePRS is also thought to repress the translation of proteins involved in other signalling pathways that are sensitive to signalling from IFNγ and hypoxia, including vascular endothelial growth factor (VeGF). This silencing is enabled by the RNA and protein interactions of the WHeP domains 34, 35 .
new domains and evolution
The three examples of TyrRS, TrpRS and ePRS are consistent with the idea that new domains fused to aaRSs are markers of new functions for these proteins. Other added domains have been identified, and their appearance correlates with the emergence of new biological functions.
More general appearance of new domains.
To investigate the full extent of the elaboration of these markers, FIG. 2 shows the appearance at specific points in evolution of all of the new domains and motifs that have been joined to eukaryotic aaRSs. Three points are clear. First, the time of initial acquisition of a eukaryote-specific domain is specific to the aaRS. The idiosyncratic nature of the initial acquisition, together with the observation that most domains and motifs are found in only one or a few aaRSs, could suggest that each aaRS has a different expanded function (or functions) [36] [37] [38] . Second, the number of aaRSs that harbour additions grows progressively as the tree of life ascends, raising the possibility that the additions themselves are part of building the complexity of higher organisms. Indeed, 19 out of 20 human aaRSs (AlaRS being the exception) have added one or more new domains or motifs. For example, the number of aaRSs harbouring the GST domain increases from two in fungi to four in insects, to five in fish and six in humans.
Third, and most striking, after a new domain has been added to an aaRS at a specific point in evolution, it is conserved from then on as an integral part of the enzyme. Thus, progressive and accretive additions of new domains or motifs to aaRSs during evolution may reflect a role in building the progressive complexity of organisms. 
New biology correlates with new functions.
To elaborate further on the possibility that these domains have roles in building the progressive complexity of organisms, we considered the development and expansion of the vascular system and the associated angiogenesis signalling pathways. If specific new domains or motifs were important for developing (or for being part of) new vascular biology associated with higher organisms, then the appearance of these domains or motifs in evolution should coincide with the emergence of the new biology. In this regard, it is interesting to note that the eLR motif and the emAPII domain of TyrRS and the WHeP domain of TrpRS (which have roles in vascular biology (see above)) are absent in Caenorhabditis elegans, which has no circulatory system. By contrast, the addition of eLR and emAPII to TyrRS first appeared with the emergence of insects, which have a primitive open circulatory system. As blood circulation further developed into the advanced closed circulatory system of vertebrates, more regulators of angio genesis were needed. extra domains (or genes) added during this transition could potentially serve such a function. Interestingly, a WHeP domain was added to TrpRS at this step. In addition, a unique sequence motif, UNe-S, emerged in the C terminus of SerRS of all vertebrates, from fish to humans. Independently, three forward-genetics mutational studies in zebrafish suggested a role for SerRS in vasculature development, which is not related to the enzymatic function of the aaRS [39] [40] [41] . Two studies suggested a role for zebrafish SerRS in regulating VeGFdirected angiogenesis 40 . Specifically, they found that two of three SerRS mutations that caused defective vasculature resulted in premature stop codons that deleted the UNe-S domain 40, 41 . Thus, we raise the possibility that the function of UNe-S is related to the development of a closed vascular system. Similarly, the biological function of the other UNes is of great research interest. It will be important to examine the correlation of domain additions with the emergence of other biological functions.
Markers are unique to aaRSs
The biological complexity of an organism is facilitated by alternative splicing of premRNAs 42 , post-translational modifications, paralogous gene duplications 43 and the adaptation of protein multifunctionality 44, 45 . Among these possibilities, multifunctionality of a single protein is considered a more efficient way to coordinate the organization and maintenance of a global system 46 , especially for solving the discrepancy of species complexity with the limited number of host genes. Over the years, numerous proteins have been found to have many distinct functions that are achieved by domain combinations or by the modification of unused surface areas [47] [48] [49] [50] . However, these multifunctional proteins belong to different protein families and their many distinct functions are specific to them. They therefore lack the coherence at the family level that is seen with aaRSs.
Among multifunctional proteins, ribosomal proteins are an interesting protein family 51 . many ribosomal proteins have multiple functions in bacteria, archaea and eukaryotes 52, 53 , and several of these functions are related to ribosomal biogenesis, such as surveillance of ribosome biosynthesis (for example, by the binding of ribosomal proteins to their own mRNAs or rRNAs). In addition, numerous ribosomal proteins have non-ribosomal functions: many bind and activate p53-related e3 ubiquitin ligase mDm2, 40S ribosomal protein S3 binds damaged DNA in D. melanogaster and nicks DNA at abasic sites in mammalian cells 51 , and 60S ribosomal protein L13a participates (together with ePRS) in the GAIT complex-mediated regulation of translation of mRNAs that are associated with inflammatory pathways 54, 55 . We were interested to see whether the expanded functions of the ribosomal proteins are also associated with new domain additions. For this purpose, a similar analysis to that described above was carried out with the ~80 cytoplasmic ribosomal proteins. In contrast to the aaRSs, more than half of the ribosomal proteins in eukaryotes Sequences of each of 79 human ribosomal proteins were analysed for appended sequences (domains or short peptide motifs) in a similar manner to that for aminoacyl-tRNA synthetases (aaRSs). The sequences were organized into four groups: similar to bacterial and archaeal orthologues (0-25 amino acids); short eukaryote-specific extensions beyond yeast (25-80 amino acids); lower eukaryote-specific extensions (found, for example, in yeast) that are longer than 80 amino acids but are not further extended in species higher than yeast; and higher eukaryote-specific extensions that were added only in species higher than yeast and that are longer than 80 amino acids. Percentages for the long extension beyond yeast group are shown. A similar analysis was done on two more protein groups. One was a group of 16 of the 17 recently identified protein markers that can be used to assemble the eukaryotic tree of life (one protein was left out because its sequence is incomplete); most members of this group have no bacterial or archaeal orthologue. The other was a group annotated as amino acid-binding proteins (Gene Ontology Database term 0016597). After removing duplicated genes, incomplete sequences and aaRSs, 16 proteins remained and were analysed.
are almost identical in length to their archaeal homologues (FIG. 3) . most of the rest have fewer than 25 amino acids as extensions at the N or C terminus, and just 7 have extensions of longer than 80 amino acids. But strikingly, no stepwise, progressive additions occurred during the long evolution of eukaryotes: most of the longer extensions of human ribosomal proteins are also seen in yeast. However, with aaRSs, progressive domain additions clearly correlate with the increasing complexity of organisms (FIG. 2) and impart functions that are unrelated to aminoacylation.
Concerned about the unusual conservation of scaffolding ribosomal proteins, we also looked at a new set of eukaryotic molecular markers 56 . These are a group of functionally different proteins, the sequences of which can be used to construct a phylogenetic tree of eukaryote evolution. These markers include the α-subunit of the transport protein Sec61, ubiquitin-activating enzyme e1 (UBA1), the spliceosome subunit U5 small nuclear ribonucleoprotein and the RNA polymerase II initiation factor TFIIH. The length of these proteins varies from 300 to ~2,000 amino acids. Again, aaRSs showed a much higher portion (60%) of domain additions in higher eukaryotes than these eukaryotic markers (12%) (FIG. 3) . A second analysis was carried out on human amino acid-binding proteins (as labelled in the Gene Ontology Database) that are shared across different species, yielding similar results.
perspective Our analysis indicates that aaRSs are unique in their acquiring of new activities through the addition of new domains that correlate with the progressive complexity of eukaryotes. It is important to note that some appended domains improve the canonical function. For example, the WHeP domain of human metRS has a tRNA-sequestering function 57 , and the Leu-zipper motif in ArgRS is important for the formation of the mSC, which can enhance channelling of tRNA to the protein synthesis machinery 58 . It is therefore possible that the added domains or motifs may have later adopted new functions beyond translation.
New domains are essential for each of the three orthogonal (that is, beyond translation) functions of the human aaRSs discussed above. We speculate that other examples will also be shown to require one or more new domains or motifs for elaboration and regulation of the orthogonal activity. Two instances, among others, are human LysRS and GlnRS, which have developed functions in the immune response and cell death. LysRS is phosphorylated through the mitogen-activated protein kinase pathway in stimulated mast cells 38 . It is then released from the cytoplasmic mSC and translocated to the nucleus, where it forms a complex with the transcription factor microphthalmiaassociated transcription factor (mITF) to enable the expression of genes that regulate the immune response. GlnRS interacts with apoptosis signal-regulating kinase 1 (ASK1; also known as mAP3K5) and inhibits cell death induced by ASK1 in a Glu-dependent manner through its catalytic domain 59 . Although their functions have not been defined, domains not directly associated with aminoacylation have been added to each of these aaRSs (FIG. 2) .
The aaRSs are ancient and were perhaps the first proteins to develop sites for binding specific amino acids. Thus, they were in an ideal spot to develop new functions. By using a pre-existing amino acid-and AmP-binding pocket, as was done for the interaction of TrpRS with the protruding side chains of Ve-cadherin, nature avoided the re-invention of another amino acid side chain-binding site 29 . Therefore, in at least some instances, the new, expanded functions of these enzymes may have been initiated through random interactions with protruding side chains on other proteins. After an initial contact, an interaction may have been further developed and refined with sophisticated domain additions to the aaRS.
If the amino acid-binding pocket played a key part as an evolutionary force to develop new protein-protein interactions, other amino acid-binding proteins might also show a progressive addition of new domains. However, our analysis showed that aaRSs have a much higher percentage of acquired sequence extensions than these amino acid-binding proteins. This result further highlights the uniqueness of aaRSs, and also shows that amino acid-binding pockets are not sufficient to explain the robust development of new domains and functions associated with aaRSs.
We raise the possibility that the domain additions in aaRSs were needed, at least in part, for the development of the complexity of organisms, by connecting aaRSs to pathways of angiogenesis 16 , the immune response 38 , inflammation 33 , apoptosis 59 and neural development 15, 60 . Because the aminoacylation activities of aaRSs are not dispensable, the new functions had to evolve in the tight constraints of an essential genetic environment. Therefore, disease-causing mutations associated with aaRSs can occur only if aminoacylation activity is kept sufficient. It is perhaps for this reason that there are many diseases associated with aaRSs 61, 62 , which in some instances do not involve the amino acylation function (such as some of the dominant mutations in the genes encoding TyrRS or GlyRSs that cause the peripheral neuropathy Charcot-marie-Tooth disease [63] [64] [65] ). It will be important to investigate (in appropriate model organisms) the effects of point mutations and deletions in newly added domains on organismal development and homeostasis. It is these kinds of experiments that can test more rigorously whether these accretive domain additions were essential for building the increasing complexity of the tree of life. However, even without these data being available at this time, the existing work suggests that the new domain additions can act as starting points for discovering more functions of eukaryotic aaRSs beyond translation and for understanding some of the many disease associations.
